Index of reports
> Cases with Febrile Neutropenia (20)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Vinorelbine where reactions include febrile neutropenia. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Vinorelbine side effects in 38 year old male
Reported by a consumer/non-health professional from Germany on 2012-08-09
Patient: 38 year old male
Reactions: Cellulitis, Febrile Neutropenia, Rash
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cisplatin
Dosage: most recent infusion 18-nov-05 (2nd infusion).
Indication: non-Small Cell Lung Cancer
Start date: 2005-10-20
Vinorelbine
Dosage: most recent infusion 24-nov-05 (4th infusion).
Indication: non-Small Cell Lung Cancer
Start date: 2005-10-20
Cetuximab
Dosage: delayed on 30-nov-05. most recent infusion 24-nov-05 (6th infusion).
Indication: non-Small Cell Lung Cancer
Start date: 2005-10-20
Possible Vinorelbine side effects in female
Reported by a physician from Chile on 2012-06-29
Patient: female, weighing 78.0 kg (171.6 pounds)
Reactions: Febrile Neutropenia
Drug(s) suspected as cause:
Vinorelbine
Dosage: 20mgm2 cyclic
Indication: Breast Cancer Metastatic
Start date: 2011-12-27
Lapatinib
Dosage: 1250mg per day
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2011-12-27
Possible Vinorelbine side effects in 63 year old male
Reported by a consumer/non-health professional from Germany on 2012-06-28
Patient: 63 year old male
Reactions: Anaemia, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cetuximab
Indication: non-Small Cell Lung Cancer
Start date: 2005-10-06
Cisplatin
Indication: non-Small Cell Lung Cancer
Start date: 2005-10-06
Vinorelbine
Indication: non-Small Cell Lung Cancer
Start date: 2005-10-06
Possible Vinorelbine side effects in
Reported by a physician from United States on 2012-06-22
Patient:
Reactions: Thrombosis, Device Related Infection, Headache, Peripheral Sensory Neuropathy, Pericardial Effusion, Malaise, Dyspepsia, Granulocytopenia, Hypoxia, Pneumonitis, Blood Alkaline Phosphatase Increased, Hyperglycaemia, Anaemia, Hypotension, Dehydration, Neutropenia, Bone Pain, Pain, Hypokalaemia, Disease Progression, Death, Postoperative Wound Infection, Fatigue, Neutropenic Infection, Chest Pain, Depression, Lethargy, Vomiting, Dyspnoea, Alanine Aminotransferase Increased, Lymphopenia, Muscular Weakness, Febrile Neutropenia, Hypophosphataemia, Syncope, Diarrhoea, Arthralgia, Ejection Fraction Decreased, Hypermagnesaemia, Respiratory Tract Infection, Leukopenia, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Docetaxel
Dosage: 60 mg/m2, unk
Indication: Breast Cancer Metastatic
Vinorelbine
Dosage: 27.5 mg/m2, per chemo regim
Indication: Breast Cancer Metastatic
Filgrastim
Dosage: 5 mug/kg, per chemo regim
Indication: Breast Cancer Metastatic
Trastuzumab
Dosage: 2 mg/kg, qwk
Trastuzumab
Dosage: 4 mg/kg, one time dose
Indication: Breast Cancer Metastatic
Possible Vinorelbine side effects in 14 year old female
Reported by a physician from United States on 2012-06-14
Patient: 14 year old female, weighing 55.0 kg (121.0 pounds)
Reactions: Atelectasis, Pneumonia, Hypotension, Febrile Neutropenia, Hypokalaemia, Pericardial Effusion, Hypoxia, Pleural Effusion, Pulmonary Oedema, Jugular Vein Thrombosis, Pneumonitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: day 1 over 30-60 minutes
Indication: Rhabdomyosarcoma
Start date: 2012-02-14
End date: 2012-02-14
Temsirolimus
Dosage: days 1, 8 and 15 over 30-60 minutes
Indication: Rhabdomyosarcoma
Start date: 2012-02-14
End date: 2012-02-28
Vinorelbine
Dosage: days 1 and 8, over 6-10 minutes
Indication: Rhabdomyosarcoma
Start date: 2012-02-01
End date: 2012-02-21
Possible Vinorelbine side effects in 14 year old female
Reported by a individual with unspecified qualification from United States on 2012-06-13
Patient: 14 year old female, weighing 55.0 kg (121.0 pounds)
Reactions: Atelectasis, Pneumonia, Hypotension, Tachycardia, Febrile Neutropenia, Pericardial Effusion, Hypokalaemia, Pulmonary Oedema, Pleural Effusion, Hypoxia, Jugular Vein Thrombosis, Pneumonitis, Oxygen Saturation Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vinorelbine
Dosage: 25 mg/m2 iv
Indication: Rhabdomyosarcoma
Start date: 2012-02-01
End date: 2012-02-21
Cyclophosphamide
Dosage: 1200 mg/m2 iv
Indication: Rhabdomyosarcoma
Start date: 2012-02-14
End date: 2012-02-14
Temsirolimus
Dosage: 15 mg/m2 iv
Indication: Rhabdomyosarcoma
Start date: 2012-02-14
End date: 2012-02-28
Possible Vinorelbine side effects in male
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-06-13
Patient: male
Reactions: Pneumonia, Interstitial Lung Disease, Hypotension, Chills, Febrile Neutropenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Mabthera
Start date: 2010-05-07
End date: 2010-11-10
Cytarabine
Indication: Lymphoma
Start date: 2010-09-03
Etoposide
Indication: Lymphoma
Start date: 2010-09-03
End date: 2010-09-05
Carboplatin
Indication: Lymphoma
Start date: 2010-09-03
End date: 2010-09-03
Gemcitabine Hydrochloride
Indication: Lymphoma
Start date: 2010-10-16
End date: 2010-10-19
Ifosfamide
Indication: Lymphoma
Start date: 2010-10-16
End date: 2010-10-19
Methylprednisolone
Start date: 2010-11-11
End date: 2010-11-14
Mabthera
Dosage: vial 500 mg/50 ml
Indication: Lymphoma
Start date: 2010-05-07
End date: 2010-10-05
Ifosfamide
Start date: 2010-11-11
End date: 2010-11-14
Vinorelbine
Indication: Lymphoma
Start date: 2010-10-19
End date: 2010-10-20
Gemcitabine Hydrochloride
Start date: 2010-11-11
End date: 2010-11-14
Mabthera
Dosage: vial 500 mg 50 ml
End date: 2010-10-15
Vinorelbine
Start date: 2010-11-11
End date: 2010-11-14
Methylprednisolone
Indication: Lymphoma
Start date: 2010-10-16
End date: 2010-10-19
Possible Vinorelbine side effects in 14 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-12
Patient: 14 year old female, weighing 55.0 kg (121.0 pounds)
Reactions: Atelectasis, Hypotension, Hypoxia, Pleural Effusion, Febrile Neutropenia, Pneumonitis, Hypokalaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Temsirolimus
Dosage: 15 mg/m2, over 30-60 minutes on days 1, 8 and 15
Indication: Rhabdomyosarcoma
Start date: 2012-02-14
End date: 2012-02-28
Cyclophosphamide
Dosage: 1200mg/m2, over 30-60 minutes on day 1
Indication: Rhabdomyosarcoma
Start date: 2012-02-14
End date: 2012-02-14
Vinorelbine
Dosage: 25 mg/m2, over 6-10 minutes on days 1 and 8
Indication: Rhabdomyosarcoma
Start date: 2012-02-01
End date: 2012-02-21
Possible Vinorelbine side effects in male
Reported by a individual with unspecified qualification from United Kingdom on 2012-05-30
Patient: male, weighing 29.1 kg (64.0 pounds)
Reactions: Febrile Neutropenia, Herpes Zoster
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Doxorubicin HCL
Indication: Sarcoma
Start date: 2011-06-28
Vinorelbine
Indication: Sarcoma
Start date: 2012-04-20
Dactinomycin
Indication: Sarcoma
Start date: 2011-06-28
Cyclophosphamide
Administration route: Oral
Indication: Sarcoma
Start date: 2012-04-20
Bevacizumab
Indication: Sarcoma
Start date: 2011-06-28
End date: 2011-07-19
Ifosfamide
Indication: Sarcoma
Start date: 2011-06-28
Vincristine
Indication: Sarcoma
Start date: 2011-06-28
Bevacizumab
Start date: 2012-04-20
Other drugs received by patient: Cotrim; Cotrim; Septra; Acetaminophen; Gabapentin
Possible Vinorelbine side effects in 65 year old male
Reported by a consumer/non-health professional from Ireland on 2012-05-23
Patient: 65 year old male
Reactions: Diarrhoea, Anaemia, Dehydration, Febrile Neutropenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cisplatin
Indication: non-Small Cell Lung Cancer
Start date: 2005-07-20
Vinorelbine
Indication: non-Small Cell Lung Cancer
Start date: 2005-07-20
Cetuximab
Indication: non-Small Cell Lung Cancer
Start date: 2005-07-20
Possible Vinorelbine side effects in male
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-05-21
Patient: male
Reactions: Pneumonia, Interstitial Lung Disease, Hypotension, Chills, Febrile Neutropenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cytarabine
Indication: Lymphoma
Start date: 2010-09-03
Methylprednisolone
Start date: 2010-11-11
End date: 2010-11-14
Carboplatin
Indication: Lymphoma
Start date: 2010-09-03
End date: 2010-09-03
Ifosfamide
Start date: 2010-11-11
End date: 2010-11-14
Mabthera
Indication: Lymphoma
Start date: 2010-05-07
End date: 2010-10-05
Etoposide
Indication: Lymphoma
Start date: 2010-09-03
End date: 2010-09-05
Vinorelbine
Start date: 2010-11-11
End date: 2010-11-14
Gemcitabine Hydrochloride
Indication: Lymphoma
Start date: 2010-10-16
End date: 2010-10-19
Gemcitabine Hydrochloride
Start date: 2010-11-11
End date: 2010-11-14
Methylprednisolone
Indication: Lymphoma
Start date: 2010-10-16
End date: 2010-10-19
Mabthera
End date: 2010-11-10
Ifosfamide
Indication: Lymphoma
Start date: 2010-10-16
End date: 2010-10-19
Vinorelbine
Indication: Lymphoma
Start date: 2010-10-19
End date: 2010-10-20
Mabthera
End date: 2010-10-15
Possible Vinorelbine side effects in 14 year old female
Reported by a physician from United States on 2012-05-16
Patient: 14 year old female, weighing 55.0 kg (121.0 pounds)
Reactions: Atelectasis, Hypotension, Hypoxia, Pleural Effusion, Febrile Neutropenia, Hypokalaemia, Pneumonitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1200mg/m2, over 30-60 minutes on day 1
Indication: Rhabdomyosarcoma
Start date: 2012-02-14
End date: 2012-02-14
Vinorelbine
Dosage: 25 mg/m2, over 6-10 minutes on days 1 and 8
Indication: Rhabdomyosarcoma
Start date: 2012-02-01
End date: 2012-02-21
Temsirolimus
Dosage: 15 mg/m2, over 30-60 minutes on days 1, 8 and 15
Indication: Rhabdomyosarcoma
Start date: 2012-02-14
End date: 2012-02-28
Possible Vinorelbine side effects in female
Reported by a physician from Peru on 2012-05-09
Patient: female, weighing 69.5 kg (152.9 pounds)
Reactions: Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Lapatinib
Dosage: 1250mg per day
Administration route: Oral
Indication: Breast Cancer
Vinorelbine
Dosage: 44mg cyclic
Indication: Breast Cancer
Possible Vinorelbine side effects in female
Reported by a physician from Chile on 2012-05-07
Patient: female, weighing 78.0 kg (171.6 pounds)
Reactions: Febrile Neutropenia
Drug(s) suspected as cause:
Lapatinib
Dosage: 1250mg per day
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2011-12-27
Vinorelbine
Dosage: 20mgm2 cyclic
Indication: Breast Cancer Metastatic
Start date: 2011-12-27
Possible Vinorelbine side effects in female
Reported by a physician from Peru on 2012-04-23
Patient: female, weighing 69.5 kg (152.9 pounds)
Reactions: Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vinorelbine
Dosage: 44mg cyclic
Indication: Breast Cancer
Lapatinib
Dosage: 1250mg per day
Administration route: Oral
Indication: Breast Cancer
Possible Vinorelbine side effects in 14 year old female
Reported by a physician from United States on 2012-04-11
Patient: 14 year old female, weighing 55.0 kg (121.0 pounds)
Reactions: Atelectasis, Hypotension, Pleural Effusion, Febrile Neutropenia, Hypoxia, Pneumonitis, Hypokalaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vinorelbine
Dosage: 25 mg/m2 iv over 6-10 minutes on days 1 and 8
Indication: Rhabdomyosarcoma
Start date: 2012-02-01
End date: 2012-02-21
Temsirolimus
Dosage: 15 mg/m2 iv over 30-60 minutes on days 1, 8 and 15
Indication: Rhabdomyosarcoma
Start date: 2012-02-14
End date: 2012-02-28
Cyclophosphamide
Dosage: 1200mg/m2/dose iv over 30-60 minutes on day 1
Indication: Rhabdomyosarcoma
Start date: 2012-02-14
End date: 2012-02-14
Possible Vinorelbine side effects in 63 year old male
Reported by a pharmacist from United States on 2012-04-02
Patient: 63 year old male, weighing 69.5 kg (152.9 pounds)
Reactions: Wheezing, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: 660 mg once iv
Indication: non-Small Cell Lung Cancer Stage IV
Start date: 2011-12-08
End date: 2012-01-05
Vinorelbine
Dosage: 35 mg qweek iv
Indication: non-Small Cell Lung Cancer Stage IV
Start date: 2011-12-29
End date: 2012-01-05
Possible Vinorelbine side effects in female
Reported by a physician from Italy on 2012-02-22
Patient: female, weighing 45.0 kg (99.0 pounds)
Reactions: Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Blinded Placebo
Dosage: code not broken
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2011-12-01
End date: 2012-01-22
Vinorelbine
Dosage: 25 mg/kg, unk
Indication: Breast Cancer Metastatic
Start date: 2011-11-30
End date: 2012-01-17
Blinded NO Treatment Received
Dosage: code not broken
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2011-12-01
End date: 2012-01-22
Comparator Trastuzumab
Dosage: 6 mg/kg, unk
Indication: Breast Cancer Metastatic
Start date: 2011-11-30
End date: 2012-01-17
Afinitor
Dosage: code not broken
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2011-12-01
End date: 2012-01-22
Possible Vinorelbine side effects in female
Reported by a physician from Poland on 2011-12-09
Patient: female, weighing 50.7 kg (111.5 pounds)
Reactions: Diarrhoea, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vinorelbine
Dosage: 20mgm2 cyclic
Indication: Breast Cancer Metastatic
Start date: 2011-11-21
Lapatinib
Dosage: 1250mg per day
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2011-07-04
Capecitabine
Dosage: 2000mgm2 cyclic
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2011-07-04
End date: 2011-11-14
Other drugs received by patient: Omeprazole
Possible Vinorelbine side effects in female
Reported by a physician from Poland on 2011-11-30
Patient: female, weighing 50.7 kg (111.5 pounds)
Reactions: Diarrhoea, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Lapatinib
Dosage: 1250mg per day
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2011-07-04
Capecitabine
Dosage: 2000mgm2 cyclic
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2011-07-04
End date: 2011-11-14
Vinorelbine
Dosage: 20mgm2 cyclic
Indication: Breast Cancer Metastatic
Start date: 2011-11-21
Other drugs received by patient: Omeprazole
|